PhotoCure Announces Plans To De-merge PCI Biotech
Oslo, Norway, Nov 16, 2007 - (Hugin via ABN Newswire) - De-merger will lead to the subsequent listing of PCI Biotech, Photocure's cancer-focused drug delivery subsidiary, on the Oslo Stock Exchange.